Back to User profile » Professor Chunying Cui
Papers published by Professor Chunying Cui:
NIR-Triggered siRNA Release and Lysosomal Escape for Synergistic Photothermal Tumor Therapy
Baldan M, Zhang S, Sun Q, Su Y, Mei D, Sun R, Zheng A, Liu D, Zhang J, Huo R, Tian Y, Han L, Wang S, Wang Y, Cui C
International Journal of Nanomedicine 2025, 20:4863-4882
Published Date: 16 April 2025
Cetuximab-Modified Human Serum Albumin Nanoparticles Co-Loaded with Doxorubicin and MDR1 siRNA for the Treatment of Drug-Resistant Breast Tumors
Yang X, Wang Y, Chen S, Zhang S, Cui C
International Journal of Nanomedicine 2021, 16:7051-7069
Published Date: 16 October 2021
Preparation Optimization of Bovine Serum Albumin Nanoparticles and Its Application for siRNA Delivery
Wang Y, Chen S, Yang X, Zhang S, Cui C
Drug Design, Development and Therapy 2021, 15:1531-1547
Published Date: 14 April 2021
Anti-HER2 functionalized graphene oxide as survivin-siRNA delivery carrier inhibits breast carcinoma growth in vitro and in vivo
Wang X, Sun Q, Cui C, Li J, Wang Y
Drug Design, Development and Therapy 2018, 12:2841-2855
Published Date: 7 September 2018
Doxorubicin and anti-VEGF siRNA co-delivery via nano-graphene oxide for enhanced cancer therapy in vitro and in vivo
Sun Q, Wang X, Cui C, Li J, Wang Y
International Journal of Nanomedicine 2018, 13:3713-3728
Published Date: 27 June 2018
Loading cisplatin onto 6-mercaptopurine covalently modified MSNS: a nanomedicine strategy to improve the outcome of cisplatin therapy
Lv X, Zhao M, Wang Y, Hu X, Wu J, Jiang X, Li S, Cui C, Peng S
Drug Design, Development and Therapy 2016, 10:3933-3946
Published Date: 1 December 2016
Design, synthesis and evaluation of VEGF-siRNA/CRS as a novel vector for gene delivery
Zhao W, Zhang YF, Jiang XY, Cui CY
Drug Design, Development and Therapy 2016, 10:3851-3865
Published Date: 24 November 2016
Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7
Bi YZ, Zhang YF, Cui CY, Ren LL, Jiang XY
International Journal of Nanomedicine 2016, 11:5771-5787
Published Date: 4 November 2016
Nanomedical strategy to prolong survival period, heighten cure rate, and lower systemic toxicity of S180 mice treated with MTX/MIT
Song N, Zhao M, Wang Y, Hu X, Wu J, Jiang X, Li S, Cui C, Peng S
Drug Design, Development and Therapy 2016, 10:2701-2711
Published Date: 30 August 2016
